BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30042209)

  • 1. Transparency of industry payments needed in clinical practice guidelines.
    Vassar M; Bibens M; Wayant C
    BMJ Evid Based Med; 2019 Feb; 24(1):8-9. PubMed ID: 30042209
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 3. New US law applies 'sunshine' to physician payments and gifts from drug, device industries.
    Woodward C
    CMAJ; 2010 Jul; 182(10):E467-8. PubMed ID: 20501787
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry relationships between physicians and professional medical associations: corrupt or essential?
    Smith CD; MacFadyen B
    Surg Endosc; 2010 Feb; 24(2):251-3. PubMed ID: 20087748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug companies will have to report all payments to US doctors from March 2014.
    Roehr B
    BMJ; 2013 Feb; 346():f826. PubMed ID: 23393117
    [No Abstract]   [Full Text] [Related]  

  • 6. Health Care Tax Inversions--Robbing Both Peter and Paul.
    Warraich HJ; Schulman KA
    N Engl J Med; 2016 Mar; 374(11):1005-7. PubMed ID: 26981932
    [No Abstract]   [Full Text] [Related]  

  • 7. Are hospitals next in line? Government investigators probing relationships between physicians, devicemakers may soon train sights on hospitals.
    Taylor M
    Mod Healthc; 2006 Aug; 36(32):24-6. PubMed ID: 16958280
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 9. An Analysis of the Open Payment Database in Neurotology.
    Ziai K; Sahyouni R; Moshtaghi O; Vu K; Goshtasbi K; Ghavami Y; Lee L; Lin HW; Djalilian HR
    Otolaryngol Head Neck Surg; 2018 Feb; 158(2):319-322. PubMed ID: 29389305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of Open Payments Receipts Among Surgical Faculty at a Large Academic Institution.
    Fazendin JM; Corey BL; Heslin MJ; Chen H
    J Surg Res; 2019 Dec; 244():599-603. PubMed ID: 31536845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial Conflicts of Interest Among Authors of Urology Clinical Practice Guidelines.
    Carlisle A; Bowers A; Wayant C; Meyer C; Vassar M
    Eur Urol; 2018 Sep; 74(3):348-354. PubMed ID: 29747945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US to require public disclosure of drug and device industry's financial ties to doctors.
    Epstein K
    BMJ; 2012 Jan; 344():e515. PubMed ID: 22262802
    [No Abstract]   [Full Text] [Related]  

  • 14. Commercialism and medicine: an overview.
    Kassirer JP
    Camb Q Healthc Ethics; 2007; 16(4):377-86; discussion 439-42. PubMed ID: 18018917
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of American College of Cardiology/American Heart Association Guideline Author Self-Disclosure Compared With Open Payments Industry Disclosure.
    Dudum R; Sajja A; Amdur RL; Choi BG
    Circ Cardiovasc Qual Outcomes; 2019 Dec; 12(12):e005613. PubMed ID: 32522012
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.
    Nalleballe K; Sheng S; Li C; Mahashabde R; Annapureddy AR; Mudassar K; Pothineni K; Veerapaneni P; Harada Y; Chilkulwar A; Ranabothu S; Brown A; Kapoor N; Onteddu S
    Stroke; 2020 Apr; 51(4):1339-1343. PubMed ID: 32078482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology: Policy for relationships with companies.
    American Society of Clinical Oncology
    J Clin Oncol; 2013 Jun; 31(16):2043-6. PubMed ID: 23610118
    [No Abstract]   [Full Text] [Related]  

  • 18. Transparency and the Doctor-Patient Relationship - Rethinking Conflict-of-Interest Disclosures.
    Adashi EY; Cohen IG; Elberg JT
    N Engl J Med; 2022 Jan; 386(4):300-302. PubMed ID: 35061340
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflicts of interest with the health industry.
    Dubois MY
    Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609
    [No Abstract]   [Full Text] [Related]  

  • 20. The Open Payments Database and Top Industry Sponsors of Plastic Surgeons: Companies and Related Devices.
    Boas SR; Niforatos JD; Summerville L; Isbester K; Chaturvedi A; Wee C; Kumar AR
    Plast Reconstr Surg; 2019 Sep; 144(3):530e-532e. PubMed ID: 31461072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.